Europe Clinical Trials Market Research Report Forecast to 2030
The increasing number of clinical trials, rising demand for Contract Research Organizations (CROs) to conduct clinical trials, and strong healthcare infrastructure are some factors propelling the Europe clinical trials market. Due to the digital transformation in clinical trials, the Europe clinical trials industry has a lot of opportunities to grow.
Clinical trials are human-participant prospective biomedical or behavioral research studies designed to answer specific questions concerning biomedical or behavioral interventions, including new treatments and recognized interventions that need additional study and comparison.
The Europe clinical trials market is growth is attributing due to the increasing number of clinical trials and strong healthcare infrastructure. Additionally, the digital transformation in clinical trials, growing incidences of diseases, and increasing approval of new active substances by the Europe Medicine Agency (EMA) will provide growth opportunities for the market in the future. However, the shortage of skilled and experienced professionals might hamper the market's growth in the forecast period.
Market Segmentation
Based on Phase, the Europe clinical trials market has been segmented into Phase I, Phase II, Phase III, And Phase IV.
Based on study design, the Europe clinical trials market has been segmented into observational, interventional, and expanded access.
Based on application, the Europe clinical trials market has been segmented into pharmaceutical, medical devices, nutrition, and others.
Based on service type, the Europe clinical trials market has been segmented into protocol designing, site identification, patient recruitment, laboratory services, bioanalytical testing services, clinical trial data management services, and others.
Based on end user, the Europe clinical trials market has been segmented into pharmaceutical & biotechnology companies, medical device companies, academic & research institutes, and nutraceutical companies.
The Europe clinical trials market includes countries such as Germany, France, the UK, Italy, Spain, Austria, and the rest of Europe. The European clinical trials market is driven by several key factors that contribute to its growth and development. The below mentioned factors align with the overall regional trends in the Europe clinical trials market.
Major Players
IQVIA (US), Laboratory Corporation of America Holdings (US), ICON PLC (Ireland), PPD Inc (US), Syneos Health (US CTI Clinical Trial and Consulting (US), Medpace Inc (US), Charles River Laboratories (US), Parexel International (MA) Corporation (US), and Antaea Medical Services Ltd (Greece).
Companies Mentioned
IQVIA (US)
Laboratory Corporation of America Holdings (US)
ICON PLC (Ireland)
PPD Inc (US)
Syneos Health (US CTI Clinical Trial and Consulting (US)
Medpace Inc (US)
Charles River Laboratories (US)
Parexel International (MA) Corporation (US)
and Antaea Medical Services Ltd (Greece).
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
- 1 Executive Summary 13
- 1.1 Overview 13
- 2 Market Introduction 14
- 2.1 Definition 14
- 2.2 Scope Of The Study 14
- 2.3 Research Objective 14
- 2.4 Market Structure 15
- 2.5 List Of Assumptions 16
- 3 Research Methodology 17
- 3.1 Overview 17
- 3.2 Data Mining 17
- 3.3 Secondary Research 18
- 3.4 Primary Research 19
- 3.4.1 Primary Interviews And Information Gathering Process 19
- 3.4.2 Breakdown Of Primary Respondents 20
- 3.5 Forecasting Techniques 20
- 3.6 Research Methodology For Market Size Estimation 21
- 3.6.1 Bottom-up Approach 22
- 3.6.2 Top-down Approach 22
- 3.7 Data Triangulation 23
- 3.8 Validation 23
- 4 Market Dynamics 24
- 4.1 Overview 24
- 4.2 Drivers 25
- 4.2.1 Increasing Number Of Clinical Trials 25
- 4.2.2 Strong Healthcare Infrastructure 25
- 4.3 Restraints 27
- 4.3.1 Shortage Of Skilled And Experienced Professionals 27
- 4.4 Opportunity 27
- 4.4.1 Digital Transformation In Clinical Trials 27
- 4.4.2 Growing Incidences Of Diseases 28
- 4.4.3 Increasing Approval Of New Active Substances By Europe Medicine Agency(Ema) 29
- 5 Market Factor Analysis 30
- 5.1 Value Chain Analysis 30
- 5.1.1 Customer Acquisition (Prepurchase Query) 31
- 5.1.2 Service Customization 31
- 5.1.3 Customer Purchase Support 31
- 5.1.4 Customer Fulfilment & Post-purchase Support 31
- 5.2 Porter's Five Forces Model 32
- 5.2.1 Threat Of New Entrants 32
- 5.2.2 Bargaining Power Of Suppliers 33
- 5.2.3 Threat Of Substitutes 33
- 5.2.4 Bargaining Power Of Buyers 33
- 5.2.5 Intensity Of Rivalry 33
- 5.3 Impact Of Covid-19 On Europe Clinical Trial Market 34
- 5.3.1 Overview 34
- 5.3.2 Impact On Pricing 34
- 5.3.3 Impact On Key Players 34
- 5.4 List Of Drugs And Devices Manufacturers Presence In Europe 35
- 6 Europe Clinical Trials Market, By Phase 37
- 6.1 Overview 37
- 6.2 Phase I 39
- 6.3 Phase Ii 40
- 6.3.1 Phase Iia 40
- 6.3.2 Phase Iib Error! Bookmark Not Defined.
- 6.4 Phase Iii 41
- 6.5 Phase Iv 42
- 7 Europe Clinical Trials Market, By Study Design 43
- 7.1 Overview 43
- 7.2 Observational 45
- 7.3 Interventional 46
- 7.4 Expanded Access 46
- 8 Europe Clinical Trials Market, By Application 47
- 8.1 Overview 47
- 8.2 Pharmaceutical 49
- 8.2.1 Neurological 50
- 8.2.2 Oncology 51
- 8.2.3 Cardiovascular 51
- 8.2.4 Infectious Diseases 52
- 8.2.5 Others 52
- 8.3 Medical Devices 53
- 8.4 Nutrition 53
- 8.5 Others 54
- 9 Europe Clinical Trials Market, By Service Type 55
- 9.1 Overview 55
- 9.2 Protocol Designing 58
- 9.3 Site Identification 58
- 9.4 Patient Recruitment 59
- 9.5 Laboratory Services 59
- 9.6 Bioanalytical Testing Services 60
- 9.7 Clinical Trial Data Management Services 60
- 9.8 Others 61
- 10 Europe Clinical Trials Market, By End User 62
- 10.1 Overview 62
- 10.2 Pharmaceutical & Biotechnology Companies 64
- 10.3 Medical Device Companies 65
- 10.4 Academic & Research Institutes 65
- 10.5 Nutraceutical Companies 66
- 11 Europe Clinical Trials Market, By Country 67
- 11.1 Overview 67
- 11.1.1 Germany 71
- 11.1.2 France 74
- 11.1.3 Uk 76
- 11.1.4 Italy 79
- 11.1.5 Spain 81
- 11.1.6 Austria 84
- 11.1.7 Rest Of Europe 86
- 12 Competitive Landscape 89
- 12.1 Overview 89
- 12.2 Competitive Benchmarking 90
- 12.3 Major Growth Strategy In The Europe Clinical Trials Market 91
- 12.4 The Leading Player In Terms Of The Number Of Developments In The Europe Clinical Trials Market 91
- 12.5 Key Development Analysis 92
- 12.6 Key Developments & Growth Strategies 92
- 12.6.1 Service Launch 92
- 12.6.2 Merger/Acquisition 93
- 12.6.3 Partnership/Collaboartion/Agreement/Expansion/Investment 93
- 12.7 Financial Matrix 94
- 12.7.1 Sales (Usd Million), 2022 94
- 12.7.2 Margins From Services Offered For Clinical Studies In The Medical Device And Pharmaceutical Area 94
- 12.7.3 Turnover Of Cros Worldwide, Europe-wide, And Germany And Austria 95
- 13.1 Charles River Laboratories 96
- 13.1.1 Company Overview 96
- 13.1.2 Financial Overview 97
- 13.1.3 Services Offered 98
- 13.1.4 Key Developments 98
- 13.1.5 Swot Analysis 99
- 13.1.6 Key Strategies 99
- 13.2 Parexel International (Ma) Corporation 100
- 13.2.1 Company Overview 100
- 13.2.2 Financial Overview 100
- 13.2.3 Services Offered 100
- 13.2.4 Key Developments 100
- 13.2.5 Key Strategies 101
- 13.3 Icon Plc 102
- 13.3.1 Company Overview 102
- 13.3.2 Financial Overview 103
- 13.3.3 Services Offered 103
- 13.3.4 Key Developments 104
- 13.3.5 Swot Analysis 105
- 13.3.6 Key Strategies 105
- 13.4 Laboratory Corporation Of America Holdings 106
- 13.4.1 Company Overview 106
- 13.4.2 Financial Overview 107
- 13.4.3 Services Offered 107
- 13.4.4 Key Developments 108
- 13.4.5 Swot Analysis 108
- 13.4.6 Key Strategies 108
- 13.5 Ppd Inc 109
- 13.5.1 Company Overview 109
- 13.5.2 Financial Overview 109
- 13.5.3 Services Offered 109
- 13.5.4 Key Developments 110
- 13.5.5 Swot Analysis 111
- 13.5.6 Key Strategies 111
- 13.6 Syneos Health 112
- 13.6.1 Company Overviews 112
- 13.6.2 Financial Overview 113
- 13.6.3 Services Offered 114
- 13.6.4 Key Developments 114
- 13.6.5 Key Strategies 114
- 13.7 Cti Clinical Trial & Consulting 115
- 13.7.1 Company Overview 115
- 13.7.2 Financial Overview 115
- 13.7.3 Services Offered 115
- 13.7.4 Key Developments 116
- 13.7.5 Key Strategies 116
- 13.8 Iqvia 117
- 13.8.1 Company Overview 117
- 13.8.2 Financial Overview 118
- 13.8.3 Services Offered 119
- 13.8.4 Key Developments 119
- 13.8.5 Swot Analysis 119
- 13.8.6 Key Strategies 119
- 13.9 Medpace Inc 120
- 13.9.1 Company Overview 120
- 13.9.2 Financial Overview 121
- 13.9.3 Services Offered 122
- 13.9.4 Key Developments 122
- 13.9.5 Key Strategies 122
- 13.10 Antaea Medical Services Ltd. 123
- 13.10.1 Company Overview 123
- 13.10.2 Financial Analysis 123
- 13.10.3 Services Offered 123
- 13.10.4 Key Developments 123
- 13.10.5 Key Strategies 123
- 14 Appendix 124
- 14.1 References 124
- 14.2 Related Reports 124
- List Of Tables
- Table 1 List Of Assumptions & Limitations 16
- Table 2 Diabetes Estimates (20-79 Years) For 2021, 2030, And 2045 28
- Table 3 Children & Adolescents And Adults With Obesity In 2020, 2025, 2030, And 2035 28
- Table 4 List Of Medical Device Manufacturers 35
- Table 5 List Of Drugs Manufacturers 36
- Table 6 Europe Clinical Trials Market, For Phase, By Country, 2019–2030 (Usd Million) 38
- Table 7 Europe Clinical Trials Market, For Phase I, By Country, 2019–2030 (Usd Million) 39
- Table 8 Europe Clinical Trials Market, For Phase Ii, By Country, 2019–2030 (Usd Million) 40
- Table 9 Europe Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 40
- Table 10 Europe Clinical Trials Market, For Phase Iia, By Country, 2019–2030 (Usd Million) 40
- Table 11 Europe Clinical Trials Market, For Phase Iib, By Country, 2019–2030 (Usd Million) 41
- Table 12 Europe Clinical Trials Market, For Phase Iii, By Country, 2019–2030 (Usd Million) 41
- Table 13 Europe Clinical Trials Market, For Phase Iii, By Country, 2019–2030 (Usd Million) 42
- Table 14 Europe Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 44
- Table 15 Europe Clinical Trials Market, For Observational, By Country, 2019–2030 (Usd Million) 45
- Table 16 Europe Clinical Trials Market, For Interventional, By Country, 2019–2030 (Usd Million) 46
- Table 17 Europe Clinical Trials Market, For Expanded Access, By Country, 2019–2030 (Usd Million) 46
- Table 18 Europe Clinical Trials Market, For Application, By Country, 2019–2030 (Usd Million) 48
- Table 19 Europe Clinical Trials Market, For Pharmaceutical, By Country, 2019–2030 (Usd Million) 49
- Table 20 Europe Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 50
- Table 21 Europe Clinical Trials Market, For Neurological, By Country, 2019–2030 (Usd Million) 50
- Table 22 Europe Clinical Trials Market, For Oncology, By Country, 2019–2030 (Usd Million) 51
- Table 23 Europe Clinical Trials Market, For Cardiovascular, By Country, 2019–2030 (Usd Million) 51
- Table 24 Europe Clinical Trials Market, For Infectious Diseases, By Country, 2019–2030 (Usd Million) 52
- Table 25 Europe Clinical Trials Market, For Others, By Country, 2019–2030 (Usd Million) 52
- Table 26 Europe Clinical Trials Market, For Medical Devices, By Country, 2019–2030 (Usd Million) 53
- Table 27 Europe Clinical Trials Market, For Nutrition, By Country, 2019–2030 (Usd Million) 53
- Table 28 Europe Clinical Trials Market, For Others, By Country, 2019–2030 (Usd Million) 54
- Table 29 Europe Clinical Trials Market, By Service Type 2019–2030 (Usd Million) 57
- Table 30 Europe Clinical Trials Market, For Protocol Designing, By Country, 2019–2030 (Usd Million) 58
- Table 31 Europe Clinical Trials Market, For Site Identification, By Country, 2019–2030 (Usd Million) 58
- Table 32 Europe Clinical Trials Market, For Patient Recruitment, By Country, 2019–2030 (Usd Million) 59
- Table 33 Europe Clinical Trials Market, For Laboratory Services, By Country, 2019–2030 (Usd Million) 59
- Table 34 Europe Clinical Trials Market, For Bioanalytical Testing Services, By Country, 2019–2030 (Usd Million) 60
- Table 35 Europe Clinical Trials Market, For Clinical Trial Data Management Services, By Country, 2019–2030 (Usd Million) 60
- Table 36 Europe Clinical Trials Market, For Others, By Country, 2019–2030 (Usd Million) 61
- Table 37 Europe Clinical Trials Market, For End User, By Country, 2019–2030 (Usd Million) 63
- Table 38 Europe Clinical Trials Market, For Pharmaceutical & Biotechnology Companies, By Country, 2019–2030 (Usd Million) 64
- Table 39 Europe Clinical Trials Market, For Medical Device Companies, By Country, 2019–2030 (Usd Million) 65
- Table 40 Europe Clinical Trials Market, For Academic & Research Institutes, By Country, 2019–2030 (Usd Million) 65
- Table 41 Europe Clinical Trials Market, For Nutraceutical Companies, By Country, 2019–2030 (Usd Million) 66
- Table 42 Europe: Clinical Trials Market, By Country, 2019–2030 (Usd Million) 70
- Table 43 Germany: Clinical Trials Market, By Phase, 2019–2030 (Usd Million) 71
- Table 44 Germany: Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 71
- Table 45 Germany: Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 72
- Table 46 Germany: Clinical Trials Market, By Application, 2019–2030 (Usd Million) 72
- Table 47 Germany: Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 72
- Table 48 Germany: Clinical Trials Market, By Service Type, 2019–2030 (Usd Million) 73
- Table 49 Germany: Clinical Trials Market By End User, 2019–2030 (Usd Million) 73
- Table 50 France: Clinical Trials Market, By Phase, 2019–2030 (Usd Million) 74
- Table 51 France: Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 74
- Table 52 France: Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 74
- Table 53 France: Clinical Trials Market, By Application, 2019–2030 (Usd Million) 75
- Table 54 France: Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 75
- Table 55 France: Clinical Trials Market, By Service Type, 2019–2030 (Usd Million) 75
- Table 56 France: Clinical Trials Market By End User, 2019–2030 (Usd Million) 76
- Table 57 Uk: Clinical Trials Market, By Phase, 2019–2030 (Usd Million) 76
- Table 58 Uk: Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 76
- Table 59 Uk: Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 77
- Table 60 Uk: Clinical Trials Market, By Application, 2019–2030 (Usd Million) 77
- Table 61 Uk: Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 77
- Table 62 Uk: Clinical Trials Market, By Service Type, 2019–2030 (Usd Million) 78
- Table 63 Uk: Clinical Trials Market By End User, 2019–2030 (Usd Million) 78
- Table 64 Italy: Clinical Trials Market, By Phase, 2019–2030 (Usd Million) 79
- Table 65 Italy: Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 79
- Table 66 Italy: Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 79
- Table 67 Italy: Clinical Trials Market, By Application, 2019–2030 (Usd Million) 80
- Table 68 Italy: Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 80
- Table 69 Italy: Clinical Trials Market, By Service Type, 2019–2030 (Usd Million) 80
- Table 70 Italy: Clinical Trials Market By End User, 2019–2030 (Usd Million) 81
- Table 71 Spain: Clinical Trials Market, By Phase, 2019–2030 (Usd Million) 81
- Table 72 Spain: Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 81
- Table 73 Spain: Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 82
- Table 74 Spain: Clinical Trials Market, By Application, 2019–2030 (Usd Million) 82
- Table 75 Spain: Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 82
- Table 76 Spain: Clinical Trials Market, By Service Type, 2019–2030 (Usd Million) 83
- Table 77 Spain: Clinical Trials Market By End User, 2019–2030 (Usd Million) 83
- Table 78 Austria: Clinical Trials Market, By Phase, 2019–2030 (Usd Million) 84
- Table 79 Austria: Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 84
- Table 80 Austria: Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 84
- Table 81 Austria: Clinical Trials Market, By Application, 2019–2030 (Usd Million) 85
- Table 82 Austria: Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 85
- Table 83 Austria: Clinical Trials Market, By Service Type, 2019–2030 (Usd Million) 85
- Table 84 Austria: Clinical Trials Market By End User, 2019–2030 (Usd Million) 86
- Table 85 Rest Of Europe: Clinical Trials Market, By Phase, 2019–2030 (Usd Million) 86
- Table 86 Rest Of Europe: Clinical Trials Market, For Phase Ii, By Type, 2019–2030 (Usd Million) 86
- Table 87 Rest Of Europe: Clinical Trials Market, By Study Design, 2019–2030 (Usd Million) 87
- Table 88 Rest Of Europe: Clinical Trials Market, By Application, 2019–2030 (Usd Million) 87
- Table 89 Rest Of Europe: Clinical Trials Market, For Pharmaceutical, By Type, 2019–2030 (Usd Million) 87
- Table 90 Rest Of Europe: Clinical Trials Market, By Service Type, 2019–2030 (Usd Million) 88
- Table 91 Rest Of Europe: Clinical Trials Market By End User, 2019–2030 (Usd Million) 88
- Table 92 Major Players In The Europe Clinical Trials Market 89
- Table 93 Most Active Player In The Europe Clinical Trials Market 91
- Table 94 Service Launch 92
- Table 95 Merger/Acquisition 93
- Table 96 Partnership/Collaboartion/Agreement/Expansion/Investment 93
- Table 97 Margins From Services Offered For Clinical Studies In The Medical Device And Pharmaceutical Area, 2022-2023 94
- Table 98 Charles River Laboratories: Services Offered 98
- Table 99 Parexel International (Ma) Corporation: Services Offered 100
- Table 100 Icon Plc: Services Offered 103
- Table 101 Icon Plc: Key Developments 104
- Table 102 Laboratory Corporation Of America Holdings: Services Offered 107
- Table 103 Ppd Inc: Services Offered 109
- Table 104 Ppd Inc: Key Developments 110
- Table 105 Syneos Health: Services Offered 114
- Table 106 Syneos Health: Key Developments 114
- Table 107 Cti Clinical Trial & Consulting: Services Offered 115
- Table 108 Iqvia: Services Offered 119
- Table 109 Medpace Inc: Services Offered 122
- Table 110 Antaea Medical Services Ltd: Services Offered 123
- List Of Figures
- Figure 1 Market Synopsis 13
- Figure 2 Europe Clinical Trials Market Structure 15
- Figure 3 Bottom-up And Top-down Approaches 21
- Figure 4 Market Dynamics: Europe Clinical Trials Market 24
- Figure 5 Driver Impact Analysis 26
- Figure 6 Restraint Impact Analysis 27
- Figure 7 Number Of New Active Substances For Diseases Approved By Ema In 2019 And 2020 29
- Figure 8 Value Chain Analysis: Europe Clinical Trials Market 30
- Figure 9 Porter's Five Forces Analysis: Europe Clinical Trials Market 32
- Figure 10 Europe Clinical Trials Market, Phase Segment Attractiveness, 2019-2030 (Usd Million) 38
- Figure 11 Europe Clinical Trials Market, By Phase, 2022 & 2030 (Usd Million) 38
- Figure 12 Europe Clinical Trials Market Share (%), By Phase, 2022 39
- Figure 13 Europe Clinical Trials Market, Study Design Segment Attractiveness, 2019-2030 (Usd Million) 43
- Figure 14 Europe Clinical Trials Market, By Study Design, 2022 & 2030 (Usd Million) 44
- Figure 15 Europe Clinical Trials Market Share (%), For Study Design, 2022 45
- Figure 16 Europe Clinical Trials Market, Application Segment Attractiveness, 2019-2030 (Usd Million) 47
- Figure 17 Europe Clinical Trials Market, By Application, 2022 & 2030 (Usd Million) 48
- Figure 18 Europe Clinical Trials Market Share (%), For Application, By Country, 2022 49
- Figure 19 Europe Clinical Trials Market, Service Type Segment Attractiveness, 2019-2030 (Usd Million) 56
- Figure 20 Europe Clinical Trials Market, By Service Type, 2022 & 2030 (Usd Million) 56
- Figure 21 Europe Clinical Trials Market Share (%), For Service Type, By Country, 2022 57
- Figure 22 Europe Clinical Trials Market, End User Segment Attractiveness, 2019-2030 (Usd Million) 62
- Figure 23 Europe Clinical Trials Market, For End User, By Country, 2022 & 2030 (Usd Million) 63
- Figure 24 Europe Clinical Trials Market Share (%), For End User, By Country, 2022 64
- Figure 25 Europe Market Analysis: Clinical Trials Market, 2019-2030 (Usd Million) 69
- Figure 26 Europe: Clinical Trials Market, By Country, 2022 & 2030 (Usd Million) 70
- Figure 27 Europe: Clinical Trials Market Share (%), By Country, 2022 71
- Figure 28 Benchmarking Of Major Competitors 90
- Figure 29 Major Strategy Adopted By Key Players In The Europe Clinical Trials Market 91
- Figure 30 Europe Fill Finish Manufacturing Market: Competitive Landscape 92
- Figure 31 Sales 2022 94
- Figure 32 Charles River Laboratories: Financial Overview Snapshot 97
- Figure 33 Charles River Laboratories: Swot Analysis 99
- Figure 34 Icon Plc: Financial Overview Snapshot 103
- Figure 35 Icon Plc: Swot Analysis 105
- Figure 36 Laboratory Corporation Of America Holdings: Financial Overview Snapshot 107
- Figure 37 Laboratory Corporation Of America Holdings: Swot Analysis 108
- Figure 38 Ppd Inc: Swot Analysis 111
- Figure 39 Syneos Health: Financial Overview Snapshot 113
- Figure 40 Iqvia: Financial Overview Snapshot 118
- Figure 41 Iqvia: Swot Analysis 119
- Figure 42 Medpace Inc: Financial Overview 121
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook